
Katie Starr joined the Department of Chemistry in 2025. Her scholarship is rooted in the drug discovery process and answering how structure determines function. She is especially interested in the synthesis of novel natural product derivatives with anti-diabetic activity. By combining traditional organic chemistry methodology with medicinal chemistry principles, her lab aims to analyze the structure-activity relationships of lead compounds and optimize their drug-like properties.
Prior to Kenyon, Starr received her Ph.D. from The Ohio State University where she worked on the synthesis of small molecule V-ATPase inhibitors with anti-ovarian cancer activity. At Ohio State, she also received the university’s Graduate Associate Leadership Award and the Teaching Online and Technology-Enhanced Teaching Endorsements from the Drake Institute for Teaching and Learning.
Areas of Expertise
Medicinal chemistry, organic chemistry, natural products
Education
2025 — Doctor of Philosophy from The Ohio State University
2022 — Master of Science from The Ohio State University
2020 — Bachelor of Science from Gannon University